Paxillin is a central protein within the focal adhesion and serves as a critical transducer of signals from fibronectin. Although abnormal expression of fibronectin and paxillin is often observed during the development of human malignancies, the relationship between paxillin and cell invasion in gastric cancer is still unclear. The current study was designed to investigate the potential role and mechanisms of fibronectin in tyrosine phosphorylation of paxillin and in the invasiveness of gastric cancer cells.
Methods
Expression of paxillin in human gastric cancer samples was examined by immunohistochemical staining. A gastric cancer cell line, AGS, was stimulated by fibronectin with gradient concentrations, and expression of paxillin and phosphorylation of paxillin tyrosine 118 (tyr118) was detected by immunoprecipitation and Western blotting. The invasiveness of AGS cells was measured by the modified Boyden chamber assay. Small interfering RNA (siRNA) targeting paxillin was used to establish the role of paxillin (tyr118) in the process of cell invasion enhanced by fibronectin. siRNA targeting focal adhesion kinase (FAK) was used to verify the effect of FAK tyrosine 397 (tyr397) on phosphorylation of paxillin(tyr118).
Results
Positivity for paxillin staining in human gastric cancer was associated with tumor stage. AGS cell showed dose dependence on fibronectin for invasiveness and phosphorylation of paxillin (tyr118). Invasiveness and phosphorylation of paxillin(tyr118) in AGS cells reached their peak when the concentration of fibronectin reached 100 nmol/L. siRNA targeting paxillin decreased the phosphorylation of paxillin(tyr118) and the invasiveness of AGS cells significantly as compared with controls. Blockage of FAK(tyr397) can inhibit phosphorylation of paxillin(tyr118) stimulated by fibronectin.
Conclusions
Fibronectin promotes paxillin(tyr118) phosphorylation and invasiveness of AGS cells. Paxillin silencing by RNA interference inhibits the cell invasiveness stimulated by fibronectin. Paxillin is a key factor in the fibronectin-stimulated invasiveness of AGS cells.
LarssonS.C., OrsiniN., WolkA.: Processed meat consumption and stomach cancer risk: a meta-analysis.J Natl Cancer Inst, 98: 1078–1087, 2006.
2.
AlbertsS.R., CervantesA., van de VeldeC.J.: Gastric cancer: epidemiology, pathology and treatment.Ann Oncol, 14: ii31–ii36, 2003.
3.
RoderD.M.: The epidemiology of gastric cancer.Gastric Cancer, 5: 5–11, 2002.
4.
WuC.W., HsiehM.C., LoS.S., TsayS.H., LuiW.Y., P'engF.K.: Relation of number of positive lymph nodes to the prognosis of patients with primary gastric adenocarcinoma.Gut, 38: 525–527, 1996.
5.
ReddigP.J., JulianoR.L.: Clinging to life: cell to matrix adhesion and cell survival.Cancer Metastasis Rev, 24: 425–439, 2005.
HumphriesM.J., ObaraM., OldenK., YamadaK.M.: Role of fibronectin in adhesion, migration, and metastasis.Cancer Invest, 7: 373–393, 1989.
14.
MargolisE.J., ChoiJ.C., ShuW.P., LiuB.C.: Specific sequences of fibronectin activate the protein kinase C signal transduction pathway in invasive bladder cancer.Cancer Lett, 100: 163–168, 1996.
15.
AhmedN., RileyC., RiceG., QuinnM.: Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment.Clin Exp Metastasis, 22: 391–402, 2005.
16.
KoulD., ShenR., BerghS., LuY., de GrootJ.F., LiuT.J., MillsG.B., YungW.K.: Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma.Mol Cancer Ther, 11: 1681–1688, 2005.
17.
ChengD.L., ShuW.P., ChoiJ.C., MargolisE.J., DrollerM.J., LiuB.C.: Bacillus Calmette-Guerin interacts with the carboxylterminal heparin binding domain of fibronectin: implications for BCG-mediated antitumor activity.J Urol, 152: 1275–1280, 1994.
BellisS.L., PerrottaJ.A., CurtisM.S., TurnerC.E.: Adhesion of fibroblasts to fibronectin stimulates both serine and tyrosine phosphorylation of paxillin.Biochem J, 25: 375–381, 1997.
24.
BangO.S., KimE.J., ChungJ.G., LeeS.R., ParkT.K., KangS.S.: Association of focal adhesion kinase with fibronectin and paxillin is required for precartilage condensation of chick mesenchymal cells.Biochem Biophys Res Commun, 278: 522–529, 2000.
25.
SalasznykR.M., KleesR.F., WilliamsW.A., BoskeyA., PlopperG.E.: Focal adhesion kinase signaling pathways regulate the osteogenic differentiation of human mesenchymal stem cells.Exp Cell Res 2007;313: 22–37.
26.
AlbiniA., IwamotoY., KleinmanH.K., MartinG.R., AaronsonS.A., KozlowskiJ.M., McEwanR.N.: A rapid in vitro assay for quantitating the invasive potential of tumor cells.Cancer Res, 47: 3239–3245, 1987.
27.
SattlerM., PisickE., MorrisonP.T., SalgiaR.: Role of the cytoskeletal protein paxillin in oncogenesis.Crit Rev Oncog, 11: 63–76, 2000.
28.
WeisbergE., SattlerM., EwaniukD.S., SalgiaR.: Role of focal adhesion proteins in signal transduction and oncogenesis.Crit Rev Oncog, 8: 343–358, 1997.
29.
SalgiaR., AvrahamS., PisickE., LiJ.L., RajaS., GreenfieldE.A., SattlerM., AvrahamH., GriffinJ.D.: The related adhesion focal tyrosine kinase forms a complex with paxillin in hematopoietic cells.J Biol Chem, 271: 31222–31226, 1996.
30.
SchallerM.D.: Paxillin: a focal adhesion-associated adaptor protein.Oncogene, 20: 6459–6472, 2001.
31.
BellisS.L., MillerJ.T., TurnerC.E.: Characterization of tyrosine phosphorylation of paxillin in vitro by focal adhesion kinase.J Biol Chem, 270: 17437–17441, 1995.
32.
SchallerM.D., SchaeferE.M.: Multiple stimuli induce tyrosine phosphorylation of the Crk-binding sites of paxillin.Biochem J, 360: 57–66, 2001.
33.
ThomasJ.W., EllisB., BoernerR.J., KnightW.B., WhiteGC2nd, SchallerM.D.: SH2- and SH3-mediated interactions between focal adhesion kinase and Src.J Biol Chem, 273: 577–583, 1998.
34.
CooleyM.A., BroomeJ.M., OhngemachC., RomerL.H., SchallerM.D.: Paxillin binding is not the sole determinant of focal adhesion localization or dominant-negative activity of focal adhesion kinase/focal adhesion kinase-related nonkinase.Mol Biol Cell, 11: 3247–3263, 2000.
35.
HuangC., JacobsonK., SchallerM.D.: A role for JNK-paxillin signaling in cell migration.Cell Cycle, 3: 4–6, 2004.
36.
TuL.C., ChouC.K., ChenH.C., YehS.F.: Protein kinase C-mediated tyrosine phosphorylation of paxillin and focal adhesion kinase requires cytoskeletal integrity and is uncoupled to mitogen-activated protein kinase activation in human hepatoma cells.J Biomed Sci, 8: 184–190, 2001.
37.
SchallerM.D.: Biochemical signals and biological responses elicited by the focal adhesion kinase.Biochim Biophys Acta, 1540: 1–21, 2001.
38.
YanoH., MazakiY., KurokawaK., HanksS.K., MatsudaM., SabeH.: Roles played by a subset of integrin signaling molecules in cadherin-based cell-cell adhesion.J Cell Biol, 166: 283–295, 2004.
39.
SchallerM.D.: FAK and paxillin: regulators of N-cadherin adhesion and inhibitors of cell migration?J Cell Biol, 166: 157–159, 2004.
40.
SchlaepferD.D., BroomeM.A., HunterT.: Fibronectin-stimulated signaling from a focal adhesion kinase-c-Src complex: involvement of the Grb2, p130cas, and Nck adaptor proteins.Mol Cell Biol, 17: 1702–1713, 1997.
41.
BrownM.C., CaryL.A., JamiesonJ.S., CooperJ.A., TurnerC.E.: Src and FAK kinases cooperate to phosphorylate paxillin kinase linker, stimulate its focal adhesion localization, and regulate cell spreading and protrusiveness.Mol Biol Cell, 16: 4316–4328, 2005.
Gabarra-NieckoV., SchallerM.D., DuntyJ.M.: FAK regulates biological processes important for the pathogenesis of cancer.Cancer Metastasis Rev, 22: 359–374, 2003.
44.
ScibelliA., d'AngeloD., PelagalliA., TafuriS., AvalloneL., Della MorteR., StaianoN.: Expression levels of the focal adhesion-associated proteins paxillin and p130CAS in canine and feline mammary tumors.Vet Res, 34: 193–202, 2003.
45.
ZengZ.Z., JiaY., HahnN.J., MarkwartS.M., RockwoodK.F., LivantD.L.: Role of focal adhesion kinase and phosphatidylinositol 3‘-kinase in integrin fibronectin receptor-mediated, matrix metalloproteinase-1-dependent invasion by metastatic prostate cancer cells.Cancer Res, 66: 8091–8099, 2006.
46.
McLeanG.W., CarragherN.O., AvizienyteE., EvansJ., BruntonV.G., FrameM.C.: The role of focal-adhesion kinase in cancer - a new therapeutic opportunity.Nat Rev Cancer, 5: 505–515, 2005.
MonN.N., ItoS., SengaT., HamaguchiM.: FAK signaling in neoplastic disorders: a linkage between inflammation and cancer.Ann NY Acad Sci, 1086: 199–212, 2006.
49.
van NimwegenM.J., van de WaterB.: Focal adhesion kinase: a potential target in cancer therapy.Biochem Pharmacol, 73: 597–609, 2007.
CaryL.A., ChangJ.F., GuanJ.L.: Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn.J Cell Sci, 109: 1787–1794, 1996.
